IQVIA Holdings Inc
F:QTS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IQVIA Holdings Inc
F:QTS
|
US |
|
F
|
Fifth Third Bancorp
XMUN:FFH
|
US |
|
F
|
Fifth Third Bancorp
DUS:FFH
|
US |
Intrinsic Value
The intrinsic value of 
IQVIA Holdings Inc (QTS) under the Base Case is 159.98 EUR per share.
Compared with the current market price of 242.5 EUR, the stock appears
Overvalued by 34% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What IQVIA Does
IQVIA Holdings helps pharmaceutical, biotech, and medical-device companies run clinical trials, manage drug data, and analyze how medicines are used in the real world. It is best known for connecting healthcare data with research services, so drug makers can design studies, recruit patients, track outcomes, and meet regulatory requirements more efficiently.
- Headquarters
- United States of America US
- Employees
- 93 000
- IPO date
- May 9, 2013
IQVIA Holdings has a narrow economic moat
Replacing IQVIA’s data and systems can require customers to rebuild connected workflows, while changing providers during an ongoing clinical trial risks costly disruption. These practical barriers help IQVIA retain customers even when competing providers offer lower prices.
Read the full moat analysis
Revenue & Expenses Breakdown
IQVIA Holdings Inc
Earnings Waterfall
IQVIA Holdings Inc
The intrinsic value for IQVIA Holdings Inc (QTS) under the Base Case is 159.98 EUR.
Compared with the current market price of 242.5 EUR, the stock appears Overvalued by 34% .